| Literature DB >> 26920199 |
Marwan M Refaat1, Akl C Fahed2, Sylvana Hassanieh3, Mostafa Hotait4, Mariam Arabi5, Hadi Skouri4, Jonathan G Seidman6, Christine E Seidman7, Fadi F Bitar5, Georges Nemer3.
Abstract
Hypertrophic cardiomyopathy (HCM) is a familial cardiac disease manifested in a wide phenotype and diverse genotype and, thus, presenting unpredictable risks mainly on young adults. Extensive studies are being conducted to categorize patients and link phenotype with genotype for a better management and control of the disease with all its complications. Because the full mechanisms behind HCM are still not revealed, therapeutics are not definitive. Further research is to be conducted for the generation of a complete picture and directed therapy for HCM.Entities:
Keywords: Genotype; Hypertrophic cardiomyopathy; Left ventricle; Muscle-bound heart; Phenotype
Mesh：
Year: 2016 PMID： 26920199 PMCID： PMC6599619 DOI： 10.1016/j.ccep.2015.10.034
Source DB: PubMed Journal: Card Electrophysiol Clin ISSN： 1877-9182